Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
51.1M
-
Number of holders
-
196
-
Total 13F shares, excl. options
-
28.5M
-
Shares change
-
+2.54M
-
Total reported value, excl. options
-
$2.15B
-
Value change
-
+$194M
-
Put/Call ratio
-
1.35
-
Number of buys
-
131
-
Number of sells
-
-70
-
Price
-
$75.50
Significant Holders of REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) as of Q3 2018
228 filings reported holding RGNX - REGENXBIO Inc. - Common Stock, par value $0.0001 per share as of Q3 2018.
REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) has 196 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.5M shares
of 51.1M outstanding shares and own 55.82% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.73M shares), Vanguard Group Inc (2.81M shares), STATE STREET CORP (1.7M shares), Redmile Group, LLC (1.66M shares), RTW INVESTMENTS, LP (1.46M shares), FMR LLC (1.09M shares), JPMORGAN CHASE & CO (1.07M shares), WS MANAGEMENT LLLP (955K shares), Invesco Ltd. (753K shares), and FRANKLIN RESOURCES INC (648K shares).
This table shows the top 196 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.